Literature DB >> 33995560

Paediatric focal nodular hyperplasia: A case study of typical contrast-enhanced ultrasound findings with quantitative analysis and correlated with magnetic resonance imaging.

Andreas Panayiotou1, Vasileios Rafailidis1, Annamaria Deganello1, Maria Sellars1, Paul S Sidhu1.   

Abstract

INTRODUCTION: Focal nodular hyperplasia, a benign liver tumour, is the second most common focal benign liver lesion, after a cavernous haemangioma. Contrast-enhanced ultrasound is used increasingly for the diagnostic work up and follow-up of focal liver lesions in adults, but is particularly valuable in the paediatric population, with the ability to reduce radiation and the nephrotoxic contrast agents used in computed tomography or magnetic resonance imaging. Confident recognition of focal nodular hyperplasia is important; it is benign, usually asymptomatic, of no clinical significance, of no clinical consequence or malignant potential. We present a case of focal nodular hyperplasia of the liver with its characteristic findings on conventional ultrasound, contrast-enhanced ultrasound with quantitative analysis and correlated with magnetic resonance imaging.Case presentation: A 15-year-old female with right upper quadrant abdominal pain was referred for liver ultrasound. A focal liver lesion was detected on B-mode ultrasound examination, and colour Doppler demonstrated no specific features. Contrast-enhanced ultrasound examination demonstrated early arterial enhancement, with a characteristic spoke-wheel pattern, centrifugal uniform filling of the lesion on the late arterial phase and sustained enhancement on the portal venous phase. Quantitative contrast-enhanced ultrasound has been performed, showing a typical curve of enhancement, as well as characteristic parametric images, supporting the interpretation of contrast-enhanced ultrasound and assisting the diagnosis. Magnetic resonance imaging demonstrated a central T2 hyperintense scar and similar enhancement characteristics as contrast-enhanced ultrasound on T1 gadolinium-enhanced sequences.
CONCLUSION: Contrast-enhanced ultrasound is a useful technique for the differentiation of benign from malignant liver lesions and has the potential to establish the diagnosis of focal nodular hyperplasia, based on the enhancement pattern, which is similar to that observed on magnetic resonance imaging but can be better appreciated with superior temporal, contrast and spatial resolution of contrast-enhanced ultrasound.
© The Author(s) 2020.

Entities:  

Keywords:  Benign tumour; contrast-enhanced ultrasound; hepatic; parametric imaging; sonographic; ultrasound

Year:  2020        PMID: 33995560      PMCID: PMC8083136          DOI: 10.1177/1742271X20947760

Source DB:  PubMed          Journal:  Ultrasound        ISSN: 1742-271X


  13 in total

Review 1.  Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.

Authors:  Shahid M Hussain; Türkan Terkivatan; Pieter E Zondervan; Esmée Lanjouw; Sjoerd de Rave; Jan N M Ijzermans; Rob A de Man
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

2.  Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu; Yan Wang; Yi-Feng Zhang; Le-Hang Guo; Chang Liu; Jun-Mei Xu; Li-Ping Sun; Jian Wu
Journal:  Clin Hemorheol Microcirc       Date:  2013       Impact factor: 2.375

3.  Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Authors:  Michel Claudon; Christoph F Dietrich; Byung Ihn Choi; David O Cosgrove; Masatoshi Kudo; Christian P Nolsøe; Fabio Piscaglia; Stephanie R Wilson; Richard G Barr; Maria C Chammas; Nitin G Chaubal; Min-Hua Chen; Dirk Andre Clevert; Jean Michel Correas; Hong Ding; Flemming Forsberg; J Brian Fowlkes; Robert N Gibson; Barry B Goldberg; Nathalie Lassau; Edward L S Leen; Robert F Mattrey; Fuminori Moriyasu; Luigi Solbiati; Hans-Peter Weskott; Hui-Xiong Xu
Journal:  Ultrasound Med Biol       Date:  2012-11-05       Impact factor: 2.998

4.  An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.

Authors:  C F Dietrich; M A Averkiou; J-M Correas; N Lassau; E Leen; F Piscaglia
Journal:  Ultraschall Med       Date:  2012-07-27       Impact factor: 6.548

5.  Contrast-enhanced ultrasound in the diagnosis of pediatric focal nodular hyperplasia and hepatic adenoma: interobserver reliability.

Authors:  Cheng Fang; Silvia Bernardo; Maria E Sellars; Annamaria Deganello; Paul S Sidhu
Journal:  Pediatr Radiol       Date:  2018-09-28

Review 6.  Role of Contrast-Enhanced Ultrasound (CEUS) in Paediatric Practice: An EFSUMB Position Statement.

Authors:  Paul S Sidhu; Vito Cantisani; Annamaria Deganello; Christoph F Dietrich; Carmina Duran; Doris Franke; Zoltan Harkanyi; Wojciech Kosiak; Vittorio Miele; Aikaterini Ntoulia; Maciej Piskunowicz; Maria E Sellars; Odd Helge Gilja
Journal:  Ultraschall Med       Date:  2016-07-14       Impact factor: 6.548

Review 7.  Enhancing the role of paediatric ultrasound with microbubbles: a review of intravenous applications.

Authors:  Vasileios Rafailidis; Annamaria Deganello; Tom Watson; Paul S Sidhu; Maria E Sellars
Journal:  Br J Radiol       Date:  2016-09-26       Impact factor: 3.039

8.  Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist).

Authors:  M Uggowitzer; C Kugler; R Gröll; H J Mischinger; R Stacher; P Fickert; A Weiglein
Journal:  Br J Radiol       Date:  1998-10       Impact factor: 3.039

9.  Focal nodular hyperplasia: with a focus on contrast enhanced ultrasound.

Authors:  Ho Suk Kang; Byung Kook Kim; Chan Sup Shim
Journal:  Korean J Hepatol       Date:  2010-12

10.  Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.

Authors:  Wen-Wen Yue; Shuo Wang; Hui-Xiong Xu; Li-Ping Sun; Le-Hang Guo; Xiao-Wan Bo; Xiao-Long Li; Chong-Ke Zhao; Dan Wang; Bo-Ji Liu
Journal:  Clin Hemorheol Microcirc       Date:  2016-11-25       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.